Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodology

Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)

(2014) Franck Bonnetain et al.   EUROPEAN JOURNAL OF CANCER

Fixed-dose rate gemcitabine alone or alternating with FOLFIRI.3 (irinotecan, leucovorin and fluorouracil) in the first-line treatment of patients with metastatic pancreatic adenocarcinoma: An AGEO randomised phase II study (FIRGEM)

(2014) Isabelle Trouilloud et al.   EUROPEAN JOURNAL OF CANCER

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Optimal Cut Points for Quality of Life Questionnaire-Core 30 (QLQ-C30) Scales: Utility for Clinical Trials and Updates of Prognostic Systems in Advanced Hepatocellular Carcinoma

(2014) M. Diouf et al.   ONCOLOGIST

Sample Size Considerations of Prediction-Validation Methods in High-Dimensional Data for Survival Outcomes

(2013) Herbert Pang et al.   GENETIC EPIDEMIOLOGY

Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy

(2013) Michael Haas et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2012) T. Seufferlein et al.   ANNALS OF ONCOLOGY

Random forests for genomic data analysis

(2012) Xi Chen et al.   GENOMICS

Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial

(2012) Sophie Gourgou-Bourgade et al.   JOURNAL OF CLINICAL ONCOLOGY

The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma

(2012) Momar Diouf et al.   JOURNAL OF HEPATOLOGY

Longitudinal Health-Related Quality of Life Assessment Implications for Prognosis in Stage IV Pancreatic Cancer

(2012) Donald P. Braun et al.   PANCREAS

Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer?

(2011) Donald P Braun et al.   Health and Quality of Life Outcomes

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

(2010) J Bernhard et al.   BRITISH JOURNAL OF CANCER

High-Dimensional Variable Selection for Survival Data

(2010) Hemant Ishwaran et al.   JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION

Pancreatic Cancer

(2010) Manuel Hidalgo   NEW ENGLAND JOURNAL OF MEDICINE

Random survival forests

(2008) Hemant Ishwaran et al.   Annals of Applied Statistics

Conditional Variable Importance for Random Forests

(2008) Carolin Strobl et al.   BMC BIOINFORMATICS

The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials

(2008) Carolyn C. Gotay et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic factor analysis of health-related quality of life data in cancer: a statistical methodological evaluation

(2008) ME Mauer et al.   Expert Review of Pharmacoeconomics & Outcomes Research